ArticleBMC cancer2024

Cost-effectiveness of ivosidenib versus chemotherapy for previously treated IDH1-mutant advanced intrahepatic cholangiocarcinoma in Taiwan.

Kuei-An Chen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.